For research use only. Not for therapeutic Use.
Methazolamide-d3 is a deuterated analog of methazolamide, labeled with three deuterium atoms. This compound is crucial in pharmacological research, particularly in the study of carbonic anhydrase inhibitors, which are used in the treatment of glaucoma and other conditions. The deuterium labeling enhances the precision of mass spectrometric analyses, allowing for accurate tracking of methazolamide in pharmacokinetic and metabolic studies. Methazolamide-d3 provides researchers with a reliable tool for investigating drug metabolism, optimizing therapeutic regimens, and studying the pharmacodynamics and pharmacokinetics of carbonic anhydrase inhibitors.
| Catalog Number | R043881 |
| CAS Number | NA |
| Synonyms | N-[5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide-d3;?5-Acetylimino-4-methyl-Δ2-1,3,4-thiadiazoline-2-sulfonamide-d3; L 584601-d3; N-[4-(Methyl-d3)-2-sulfamoyl-Δ2-1,3,4-thiadiazolin-5-ylidene]acetamide; Methenamide-d3; Neptazane- |
| Molecular Formula | C₅H₅D₃N₄O₃S₂ |
| Purity | ≥95% |
| Storage | 4°C |
